SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-249225
Filing Date
2022-09-22
Accepted
2022-09-22 16:33:03
Documents
12
Period of Report
2022-09-16
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K d325698d8k.htm   iXBRL 8-K 22339
  Complete submission text file 0001193125-22-249225.txt   139331

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cort-20220916.xsd EX-101.SCH 2857
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE cort-20220916_lab.xml EX-101.LAB 17236
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cort-20220916_pre.xml EX-101.PRE 10813
6 EXTRACTED XBRL INSTANCE DOCUMENT d325698d8k_htm.xml XML 3273
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50679 | Film No.: 221259586
SIC: 2834 Pharmaceutical Preparations